FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099384791> ?p ?o ?g. }

• W2099384791 endingPage "4378" @default.
• W2099384791 startingPage "4370" @default.
• W2099384791 abstract "In this multicenter retrospective study, the outcomes of 234 patients with myelodysplastic syndrome (MDS) who underwent transplantation between 1995 and 1999 from HLA-identical siblings were analyzed according to the hematopoietic stem cell source used, that is, bone marrow (BM, n = 132) or granulocyte colony-stimulating factor–mobilized peripheral blood progenitor cells (PBPCs, n = 102). There were 69 cases of refractory anemia (RA), 86 RA with excess blasts (RAEB), 75 RAEB in transformation (RAEB-t), and 4 unclassified MDS at diagnosis. The International Prognostic Scoring System was intermediate-2 or high in 104 of the 158 available scores. Multivariate analyses focused on transplantation-related mortality (TRM), 2-year treatment failure incidence, and survival. Use of PBPCs reduced the median duration of neutropenia and thrombocytopenia by 4 and 12 days, respectively. The incidence of acute GVHD was similar whatever the graft type used. Chronic GVHD was more likely to have occurred with PBPCs (odds ratio [OR], 1.62; 95% confidence interval [CI], 0.87-3.02). Two-year TRM was significantly reduced with PBPCs (relative risk [RR], 0.33; 95% CI, 0.15-0.73; P < .007), except for patients who had either RA or high-risk cytogenetics. The 2-year treatment failure incidence was significantly decreased with PBPCs, from 38% to 13% (RR, 0.22; 95% CI, 0.10-0.48;P < .001). Estimate of the 2-year event-free survival was 50% with PBPCs versus 39% with BM. In multivariate analysis, the outcome was significantly improved with PBPCs (RR, 0.27; 95% CI, 0.13-0.52; P < .001), except for patients with either RA or high-risk cytogenetics. In conclusion, PBPCs might be preferred for allogeneic transplantation in MDS patients at high risk for relapse on the basis of morphologic criteria because the use of this hematopoietic stem cell was associated with lower treatment failure incidence and improved survival." @default.
• W2099384791 created "2016-06-24" @default.
• W2099384791 creator A5019377904 @default.
• W2099384791 creator A5022712318 @default.
• W2099384791 creator A5027302651 @default.
• W2099384791 creator A5029260153 @default.
• W2099384791 creator A5034779401 @default.
• W2099384791 creator A5034871851 @default.
• W2099384791 creator A5035666187 @default.
• W2099384791 creator A5042734609 @default.
• W2099384791 creator A5046661856 @default.
• W2099384791 creator A5049172299 @default.
• W2099384791 creator A5049735878 @default.
• W2099384791 creator A5058677948 @default.
• W2099384791 creator A5062839406 @default.
• W2099384791 creator A5066560929 @default.
• W2099384791 creator A5081252933 @default.
• W2099384791 creator A5085132315 @default.
• W2099384791 date "2002-05-29" @default.
• W2099384791 modified "2023-10-17" @default.
• W2099384791 title "Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes" @default.
• W2099384791 cites W116615943 @default.
• W2099384791 cites W149003550 @default.
• W2099384791 cites W1548612891 @default.
• W2099384791 cites W1580788756 @default.
• W2099384791 cites W1620751085 @default.
• W2099384791 cites W1856810180 @default.
• W2099384791 cites W187238933 @default.
• W2099384791 cites W190201512 @default.
• W2099384791 cites W1934677454 @default.
• W2099384791 cites W1965974612 @default.
• W2099384791 cites W1965979673 @default.
• W2099384791 cites W1979300931 @default.
• W2099384791 cites W1985301272 @default.
• W2099384791 cites W1987968353 @default.
• W2099384791 cites W1991125854 @default.
• W2099384791 cites W2053278212 @default.
• W2099384791 cites W2069566335 @default.
• W2099384791 cites W2071360821 @default.
• W2099384791 cites W2093825731 @default.
• W2099384791 cites W2129925362 @default.
• W2099384791 cites W2137960776 @default.
• W2099384791 cites W2163682534 @default.
• W2099384791 cites W2190162667 @default.
• W2099384791 cites W2247784410 @default.
• W2099384791 cites W2262982217 @default.
• W2099384791 cites W2278599555 @default.
• W2099384791 cites W2292001986 @default.
• W2099384791 cites W2337680764 @default.
• W2099384791 cites W2395542025 @default.
• W2099384791 cites W2410096256 @default.
• W2099384791 cites W2414467096 @default.
• W2099384791 cites W2444239232 @default.
• W2099384791 cites W347010909 @default.
• W2099384791 cites W5387557 @default.
• W2099384791 cites W1983392832 @default.
• W2099384791 doi "https://doi.org/10.1182/blood.v99.12.4370" @default.
• W2099384791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12036864" @default.
• W2099384791 hasPublicationYear "2002" @default.
• W2099384791 type Work @default.
• W2099384791 sameAs 2099384791 @default.
• W2099384791 citedByCount "137" @default.
• W2099384791 countsByYear W20993847912012 @default.
• W2099384791 countsByYear W20993847912013 @default.
• W2099384791 countsByYear W20993847912014 @default.
• W2099384791 countsByYear W20993847912015 @default.
• W2099384791 countsByYear W20993847912016 @default.
• W2099384791 countsByYear W20993847912017 @default.
• W2099384791 countsByYear W20993847912018 @default.
• W2099384791 countsByYear W20993847912019 @default.
• W2099384791 countsByYear W20993847912020 @default.
• W2099384791 countsByYear W20993847912021 @default.
• W2099384791 countsByYear W20993847912022 @default.
• W2099384791 countsByYear W20993847912023 @default.
• W2099384791 crossrefType "journal-article" @default.
• W2099384791 hasAuthorship W2099384791A5019377904 @default.
• W2099384791 hasAuthorship W2099384791A5022712318 @default.
• W2099384791 hasAuthorship W2099384791A5027302651 @default.
• W2099384791 hasAuthorship W2099384791A5029260153 @default.
• W2099384791 hasAuthorship W2099384791A5034779401 @default.
• W2099384791 hasAuthorship W2099384791A5034871851 @default.
• W2099384791 hasAuthorship W2099384791A5035666187 @default.
• W2099384791 hasAuthorship W2099384791A5042734609 @default.
• W2099384791 hasAuthorship W2099384791A5046661856 @default.
• W2099384791 hasAuthorship W2099384791A5049172299 @default.
• W2099384791 hasAuthorship W2099384791A5049735878 @default.
• W2099384791 hasAuthorship W2099384791A5058677948 @default.
• W2099384791 hasAuthorship W2099384791A5062839406 @default.
• W2099384791 hasAuthorship W2099384791A5066560929 @default.
• W2099384791 hasAuthorship W2099384791A5081252933 @default.
• W2099384791 hasAuthorship W2099384791A5085132315 @default.
• W2099384791 hasBestOaLocation W20993847911 @default.
• W2099384791 hasConcept C126322002 @default.
• W2099384791 hasConcept C143998085 @default.
• W2099384791 hasConcept C201750760 @default.
• W2099384791 hasConcept C2776694085 @default.
• W2099384791 hasConcept C2777063308 @default.
• W2099384791 hasConcept C2777408962 @default.

• next